JPS55153717A - Preparation of ubidecarenone soft capsule - Google Patents

Preparation of ubidecarenone soft capsule

Info

Publication number
JPS55153717A
JPS55153717A JP6129379A JP6129379A JPS55153717A JP S55153717 A JPS55153717 A JP S55153717A JP 6129379 A JP6129379 A JP 6129379A JP 6129379 A JP6129379 A JP 6129379A JP S55153717 A JPS55153717 A JP S55153717A
Authority
JP
Japan
Prior art keywords
ubidecarenone
oil
active ingredient
resulting solution
surface active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6129379A
Other languages
Japanese (ja)
Inventor
Tatsu Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOKAI KAPUSERU KK
Tokai Capsule Co Ltd
Original Assignee
TOKAI KAPUSERU KK
Tokai Capsule Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOKAI KAPUSERU KK, Tokai Capsule Co Ltd filed Critical TOKAI KAPUSERU KK
Priority to JP6129379A priority Critical patent/JPS55153717A/en
Publication of JPS55153717A publication Critical patent/JPS55153717A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: To obtain the title capsule useful as a remedy for heart diseare, having long-term stability, by dissolving ubidecarenone in a combination of a specific surface active ingredient and specified oil, followed by sealing the resulting solution with a capsuling agent.
CONSTITUTION: Ubidecarenone and Polysorbase 80 or polyoxyethylene hardened caster oil as a surface active ingredient are disolved in a middle-chain fatty oil. The resulting solution is sealed in a base for a capsule (e.g., gelatin) to give ubidecarenone soft capsules. Prepared capsules are transparent and very stable, and the precipitation of crystal will not occur even in long-term storage at low temperatures not higher than 5°C.
COPYRIGHT: (C)1980,JPO&Japio
JP6129379A 1979-05-18 1979-05-18 Preparation of ubidecarenone soft capsule Pending JPS55153717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6129379A JPS55153717A (en) 1979-05-18 1979-05-18 Preparation of ubidecarenone soft capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6129379A JPS55153717A (en) 1979-05-18 1979-05-18 Preparation of ubidecarenone soft capsule

Publications (1)

Publication Number Publication Date
JPS55153717A true JPS55153717A (en) 1980-11-29

Family

ID=13166994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6129379A Pending JPS55153717A (en) 1979-05-18 1979-05-18 Preparation of ubidecarenone soft capsule

Country Status (1)

Country Link
JP (1) JPS55153717A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023349A2 (en) * 1979-07-25 1981-02-04 Eisai Co., Ltd. Ubidecarenone composition enhancing the absorption
EP0617957A1 (en) * 1993-03-30 1994-10-05 INVERNI DELLA BEFFA FARMACEUTICI S.r.l. Oral formulations of ubidecarenone in form of capsules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023349A2 (en) * 1979-07-25 1981-02-04 Eisai Co., Ltd. Ubidecarenone composition enhancing the absorption
EP0617957A1 (en) * 1993-03-30 1994-10-05 INVERNI DELLA BEFFA FARMACEUTICI S.r.l. Oral formulations of ubidecarenone in form of capsules

Similar Documents

Publication Publication Date Title
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
JPS53107408A (en) Micellar preparation for rectal infusion
JPS51148013A (en) Stable insulin preparation for nosal administration
GB1494859A (en) Encapsulated digoxin solutions and method of preparing the same
NO882615D0 (en) PHARMACEUTICAL PREPARATION WITH FINALLY SHARED EBSELEN CRYSTALS.
IE40361L (en) Bismuth containing pharmaceutical compositions
JPS5581813A (en) Composition containing coenzyme q10 and its perparation
KR940021054A (en) Capsule-type ubidecarenone oral preparation
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
JPS52128210A (en) Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives
JPS52139713A (en) Sustained release cefalexin preparations
JPS55153717A (en) Preparation of ubidecarenone soft capsule
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS5350316A (en) Drug composition for oral administration
IE801914L (en) Paracetamol compositions
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS5387986A (en) Display element
KR850006136A (en) Etoposide Oral Dosage Form
IE800179L (en) Pharmaceutical compositions containing paracetamol.
JPS51144733A (en) A remedy for hepatic failure
JPS5726587A (en) Stabilization of ascorbic acid oxidase
JPS5340779A (en) Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS51120878A (en) Monument
JPS5318529A (en) Optically active mandelic acid phenylglycinol salt and its preparation
JPS52130905A (en) Medicinal composition